The quest for effective Ebola treatment: Ebola VP35 is an evidence-based target for dsRNA drugs
Emerg Microbes Infect
.
2014 Oct;3(10):e77.
doi: 10.1038/emi.2014.77.
Epub 2014 Oct 29.
Authors
William M Mitchell
1
,
William A Carter
2
Affiliations
1
Department of Pathology, Microbiology and Immunology, Vanderbilt University , Nashville, TN 37232, USA.
2
Hemispherx Biopharma, Inc. , Philadelphia, PA 19103, USA.
PMID:
26038500
PMCID:
PMC4217096
DOI:
10.1038/emi.2014.77
No abstract available